Navigation Links
Arrowhead Releases New Report Assessing State of Personalized Medicine Market
Date:5/18/2010

The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming increasingly important.

Minneapolis, MN (PRWEB) May 18, 2010 -- The era of Personalized Medicine is set to revolutionize the healthcare industry. As our knowledge of genetics and molecular biology rapidly expands, a personalized approach to medical care is becoming increasingly important.

Not only does this paradigm promise to improve an individual’s treatment outcome and reduce healthcare expenditure, personalized medicine is set to transform the biopharmaceutical and molecular diagnostics markets.

Arrowhead’s Personalized Medicine 2010 report provides an in-depth assessment of this burgeoning market, and examines the major challenges that need to be overcome to maximize success.

Key features of Arrowhead’s Personalized Medicine 2010 include:

Case studies of leading pharmacogenomic products
Analysis of the personalized medicine market, including seven major market sales forecasts to 2016
Regulatory and legal issues surrounding personalized medicine
Payer reimbursement challenges
Marketing strategies to capitalize profits

Key questions answered by Arrowhead’s Personalized Medicine 2010 include:

What are the major challenges in this market and how can these be overcome?
How will pharmacogenomics transform clinical trials?
What are the leading pharmacogenomic products on the market?
Who are the key playe
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The Biggest Names in the Field of Personalized Medicine to Speak at Arrowhead's Upcoming 2009 Personalized Medicine Conference
2. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
3. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
4. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
5. ARUP Laboratories Releases ARUP Consult(R) 2.0
6. Rabobank Releases Annual North American Food & Agribusiness Outlook
7. National Nanotechnology Initiative releases new strategic plan
8. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
9. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
10. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
11. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at BioCentury,s NewsMakers in the Biotech Industry conference ... from the Millennium Broadway Hotel & Conference Center in ... presentation can be accessed at www.meipharma.com . A replay ...
(Date:9/18/2014)... ST. LOUIS , Sept. 18, 2014 /PRNewswire/ ... ) announced today it has entered into a ... Michigan (U-M) Medical School,s Vector Core. Under the ... Sigma CRISPR technology, experimental design consultation, and dedicated ... poised to accelerate gene editing-based research at the ...
(Date:9/18/2014)... Now a team led by an engineer at Michigan ... that will let scientists slash the cost of one ... Syringe pumps are used to dispatch precise amounts of ... a reaction. They can also cost hundreds or even ... of Michigan Tech students published the library of free ...
(Date:9/18/2014)... The quest for the ultimate memory device for computing ... at The City College of New York led by ... exhibit both magnetic and ferroelectric properties. , Combining both ... can occur between them and for the devices that ... Combining these two properties in a single material, however, ...
Breaking Biology Technology:MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4Doing science just got cheaper -- and faster 2Oxides discovered by CCNY team could advance memory devices 2
... California (USC) have, for the first time in history, derived ... will enable scientists to create far more effective animal models ... , The research will be published in the Dec. 26 ... is a major development in stem cell research because we ...
... bacteria. However, how the step from gene to anti-bacterial effect ... B. Pseudomallei, a bacterium suitable for bioweapons, had ... human body for many years without being detected by the ... throughout the body, resulting in the patient dying from blood ...
... researcher has created a compound that prevents replication of the ... for the disease. , "The outbreak of SARS in 2003 ... there is currently no treatment," said Arun Ghosh, the Purdue ... not currently a threat, there is the concern that SARS ...
Cached Biology Technology:USC researchers derive first embryonic stem cells from rats 2USC researchers derive first embryonic stem cells from rats 3Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3
(Date:9/18/2014)... a world-leading provider of scientific, technical and medical ... Management Society (ARMS), recognized the academic research achievements ... Young Researcher of the Year Awards. , The ... Convention Centre and in conjunction with the ARMS ... Australia,s and New Zealand,s scientific community. Guest of ...
(Date:9/18/2014)... their entire lives nestling in the protective tentacles of ... they sometimes travel hundreds of kilometres across the open ... fish has been predicted, this is the first time ... populations has been observed. , Dr Steve Simpson, Senior ... University of Exeter, and colleagues from the Australian Research ...
(Date:9/17/2014)... Fauna Europaea started in 2000 as an EC-FP5 four-year ... years of steady progress and successful participations in several ... European Biodiversity Observation Network project (EU BON), to ... the contributors and to extend the general dissemination of ... Journal has applied its novel e-Publishing tools ...
Breaking Biology News(10 mins):Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Expedition finds Nemo can travel great distances to connect populations 2Expedition finds Nemo can travel great distances to connect populations 3Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2
... Hopkins engineer is trying to coax human stem cells ... could someday be used to replace damaged tissue in ... Sharon Gerecht, an assistant professor of chemical and molecular ... received a $150,000 two-year grant from the March of ...
... Computational Biology (ISCB) are delighted to announce a new ... will once again become an official journal of ... and the ISCB have always shared close links which ... ISCB members enjoy a substantial discount on the individual ...
... trip to Puerto Rico, ecologist James Porter took samples from ... of radioactive matter instead he found a link to ... were to unexploded bombs from the World War II vessel ... carcinogenic materials. "Unexploded bombs are in the ocean ...
Cached Biology News:Researcher seeks to turn stem cells into blood vessels 2Researcher seeks to turn stem cells into blood vessels 3Link between unexploded munitions in oceans and cancer-causing toxins determined 2
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD69 TAC is designed to deplete human CD69 from samples to isolate resting CD4+ or CD8+ T cells....
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
No-Weigh Dithiothreitol (DTT) ,7.7 mg DTT/Tube x 48 tubes...
Biology Products: